FDA Inspection 1202151 — South Florida Institute for Reproductive Medicine
The FDA completed an inspection of South Florida Institute for Reproductive Medicine on April 6, 2023 in Jupiter, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 6, 2023
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Jupiter, FL (United States)